Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology, non-alcoholic steatohepatitis and obesity, announced that it has granted as of August 1, 2023 an equity inducement award to one new employee under the terms of the 2022 Employment Inducement Award Plan.
August 3, 2023
· 1 min read